Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2012
Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapyQin Li, Guillermina Lozano
Genes & Development|August 17, 2014
Limiting the power of p53 through the ubiquitin proteasome pathwayVinod Pant, Guillermina Lozano
Nature Reviews. Cancer|September 25, 2009
20 years studying p53 functions in genetically engineered miceLawrence A Donehower, Guillermina Lozano
Cancer Cell|March 3, 2009
p53 and MDM2: antagonists or partners in crime?Christine M Eischen, Guillermina Lozano
Developmental Cell|March 15, 2013
Mir-125a-5p-mediated regulation of Lfng is essential for the avian segmentation clockMaurisa F Riley, Matthew S Bochter, Kanu Wahi, et al.
Genes & Development|March 2, 2018
SNPing away at mutant p53 activitiesGuadalupe J Ortiz, Guillermina Lozano
Human Mutation|March 6, 2003
Disrupting TP53 in mouse models of human cancersJohn M Parant, Guillermina Lozano
Cancer Cell|July 19, 2005
Gankyrin: an intriguing name for a novel regulator of p53 and RBGuillermina Lozano, Gerard P Zambetti
Genes & Development|September 19, 2012
The p53 family grows oldElsa R Flores, Guillermina Lozano
Pageof 18